In summary, a large number of sleep health providers who responded to our survey reported that they curtailed in-laboratory sleep studies by at least 90%, while a majority
curtailed HSAT and expanded the use of telemedicine visits in the early days of the COVID-19 pandemic. What remains to be seen is how these changes impact patient and health care provider acceptability, health, and safety in the long term, and whether regulatory and payment models will continue to support these changes in the months and years to come. Whether these changes are a transient response to a worldwide emergency or a permanent transformation in sleep medicine health care delivery remains to be seen.
Comentários